Hidradenitis Suppurativa

  • Deanna M. SikorskiEmail author
  • Kenneth J. Tomecki


Hidradenitis suppurativa (HS), also known as acne inversa, is a chronic, debilitating inflammatory disease characterized by painful subcutaneous nodules and abscesses of intertriginous areas that contain both apocrine glands and terminal hairs.


Myocutaneous Flap Epidural Abscess Cyproterone Acetate Hidradenitis Suppurativa Apocrine Gland 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60:539–61.PubMedCrossRefGoogle Scholar
  2. 2.
    Revuz JE, Canoui-poitrine F, Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case–control studies. J Am Acad Dermatol. 2008;59:596–601.PubMedCrossRefGoogle Scholar
  3. 3.
    Wang B, Yang W, Wen W, et al. Gamma-secretase gene mutations in familial acne inversa. Science. 2010;330:1065.PubMedCrossRefGoogle Scholar
  4. 4.
    Danby FW, Margesson LJ. Hidradenitis suppurativa. Dermatol Clin. 2010;28:779–93.PubMedCrossRefGoogle Scholar
  5. 5.
    Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol. 2010;62:706–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Moosbrugger EA, Mutasim DF. Hidradenitis suppurativa complicated by severe lymphedema and lymphangiectasias. J Am Acad Dermatol. 2011;64:1223–4.3.PubMedCrossRefGoogle Scholar
  7. 7.
    Simonart T. Hidradenitis suppurativa and smoking. J Am Acad Dermatol. 2010;62:149–50.PubMedCrossRefGoogle Scholar
  8. 8.
    Wall D, Kirby B. Rifampicin and clindamycin for hidradenitis. J Am Acad Dermatol. 2011; 64:790.PubMedCrossRefGoogle Scholar
  9. 9.
    Grant A, Gonzalez T, Montgomery MO, Cardenas V, Kerdel FA. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62:205–17.PubMedCrossRefGoogle Scholar
  10. 10.
    Lee RA, Dommasch E, Treat J, et al. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2009;60:565–73.PubMedCrossRefGoogle Scholar
  11. 11.
    Blanco R, Martínez-Taboada VM, Villa I, et al. Long-term successful adalimumab therapy in severe hidradenitis suppurativa. Arch Dermatol. 2010;145:580–84.CrossRefGoogle Scholar
  12. 12.
    Mahmoud BH, Tierney E, Hexsel CL, Pui J, Ozog DM, Hamzavi IH. Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser. J Am Acad Dermatol. 2010;62:637–45.PubMedCrossRefGoogle Scholar
  13. 13.
    Syed ZU, Hamzavi IH. Photomedicine and phototherapy considerations for patients with skin of color. Photodermatol Photoimmunol Photomed. 2011;27:10.PubMedCrossRefGoogle Scholar
  14. 14.
    Rambhatla PV, Lim HW, Hamzavi I. A systematic review of treatments for hidradenitis suppurativa. Arch Dermatol. 2012;148:439–46.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of DermatologyThe Cleveland Clinic FoundationClevelandUSA

Personalised recommendations